Intravesical injection of botulinum toxin type A: Management of neuropathic bladder and bowel dysfunction in children with myelomeningocele

Urology

Volumn 68, Issue 5, 2006, Pages 1091-1096

  Kajbafzadeh, Abdol Mohammad ^a   Moosavi, Shahram ^b   Tajik, Parvin ^c   Arshadi, Hamid ^a   Payabvash, Seyedmehdi ^a   Salmasi, Amirali H ^a   Akbari, Hamid R ^d   Nejat, Farideh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

ADOLESCENT; ARTICLE; BLADDER CAPACITY; BLADDER DISEASE; BLADDER PRESSURE; CHILD; CLINICAL ARTICLE; CYSTOSCOPY; DETRUSOR HYPERREFLEXIA; DETRUSOR MUSCLE; DRUG EFFICACY; ENTEROPATHY; FEMALE; HUMAN; HYPERREFLEXIA; INTERMITTENT CATHETERIZATION; MALE; MENINGOMYELOCELE; MICTURITION CYSTOURETHROGRAPHY; MUSCLE WEAKNESS; NEUROPATHIC BLADDER; PRIORITY JOURNAL; URINARY TRACT INFECTION; URINE INCONTINENCE; VESICOURETERAL REFLUX;

ADMINISTRATION, INTRAVESICAL; ADOLESCENT; BOTULINUM TOXIN TYPE A; CHILD; CHILD, PRESCHOOL; FECAL INCONTINENCE; FEMALE; HUMANS; MALE; MENINGOMYELOCELE; PROSPECTIVE STUDIES; URINARY BLADDER, NEUROGENIC; URINARY INCONTINENCE;

EID: 33750983916     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.05.056     Document Type: Article

References (21)

1. Younoszai M.K. Stooling problems in patients with myelomeningocele. South Med J 85 (1992) 718-722
2. Goessl C., Knispel H.H., Fiedler U., et al. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology 51 (1998) 94-98
3. Cruz F., Guimaraes M., Silva C., et al. Suppression of bladder hyperreflexia by intravesical resiniferatoxin. Lancet 350 (1997) 640-641
4. Cardozo L.D., Abrams P.D., Stanton S.L., et al. Idiopathic detrusor instability treated by biofeedback. Br J Urol 50 (1978) 521-523
5. Schmidt R.A. Application of neurostimulation in urology. Neurourol Urodyn 7 (1998) 585-589
6. Palmer L.S., Richards I., and Kaplan W.E. Transrectal electrostimulation therapy for neuropathic bowel dysfunction in children with myelomeningocele. J Urol 157 (1997) 1449-1452
7. Schurch B., Stohrer M., Kramer G., et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs?. Preliminary results. J Urol 164 (2000) 692-697
8. Riccabona M., Koen M., Schindler M., et al. Botulinum-A toxin injection into the detrusor: a safe alternative in the treatment of children with myelomeningocele with detrusor hyperreflexia. J Urol 171 (2004) 845-848
9. Schulte-Baukloh H., Michael T., Schobert J., et al. Efficacy of botulinum-a toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results. Urology 59 (2002) 325-328
10. Cayan S., Coskun B., Bozlu M., et al. Botulinum toxin type A may improve bladder function in a rat chemical cystitis model. Urol Res 30 (2003) 399-404
11. Dykstra D., Enriquez A., and Valley M. Treatment of overactive bladder with botulinum toxin type B: a pilot study. Int Urogynecol J 14 (2003) 424-426
12. Kajbafzadeh A.M., and Chubak N. Simultaneous Malone antegrade continent enema and Mitrofanoff principle using the divided appendix: report of a new technique for prevention of stoma complications. J Urol 165 (2001) 2404-2409
13. Mor Y., Kajbafzadeh A.M., German K., et al. The role of ureter in the creation of Mitrofanoff channels in children. J Urol 157 (1997) 635-637
14. Kuo H.C. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents. Urology 63 (2004) 868-872
15. Dykstra D.D., Sidi A., Scott A.B., et al. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol 139 (1988) 919-922
16. Schurch B., Hauri D., Rodic B., et al. Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol 155 (1996) 1023-1029
17. Haferkamp A., Schurch B., Reitz A., et al. Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder. Eur Urol 46 (2004) 784-791
18. Apostolidis A., Popat R., Yiangou Y., et al. A possible explanation for the exceptional efficacy of botulinum toxin treatment for detrusor overactivity. Neurourol Urodyn 23 (2004) 608-609
19. Harper M., Fowler C.J., and Dasgupta P. Botulinum toxin and its applications in the lower urinary tract. BJU Int 93 (2004) 702-706
20. Schmidt R.A., Kogan B.A., and Tanagho E.A. Neuroprosthesis in the management of incontinence in myelomeningocele patients. J Urol 143 (1990) 779-804
21. Wyndaele J.J., and van Dromme S.A. Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40 (2002) 599-600